Biotech

All Articles

Ascendis' dwarfism medication smash hits in stage 3, intimidates BioMarin

.Ascendis Pharma has actually become a prospective threat to BioMarin's Voxzogo, mentioning phase 3 ...

Despite ph. 3 miss out on, Alkeus sees pathway ahead of time for eye ailment resource

.Though Alkeus Pharmaceuticals' oral eye disease asset failed to substantially decrease geographical...

Kairos goes social with $6M IPO to money tests of cancer medication

.Along with a trio of biotechs attacking the Nasdaq on Friday, it was actually easy to miss out on a...

Vaccine and Keytruda combination efficient in squamous cell cancer

.Immune gate preventions are actually the superheroes of cancer cells treatment. Drugs like Bristol ...

Cue Biopharma queues up J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant management hirings, shootings...

Regeneron's Opdualag competitor shows 57% action cost

.Regeneron is actually back with long-lasting consequence for its own LAG-3 prevention and PD-1 inhi...

AstraZeneca messages records on internal opponents to AbbVie, Pfizer ADCs

.AstraZeneca has shared an early consider the performance of its own internal antibody-drug conjugat...

iTeos- GSK's TIGIT celebrity presents significant remodeling

.After announcing a stage 3 launch based on good midstage results, iTeos and GSK are actually lastly...

More joint FDA may speed up unusual ailment R&ampD: document

.The FDA ought to be actually a lot more open and joint to unleash a rise in commendations of rare c...

Zenas, MBX, Bicara head to Nasdaq in hot time for biotech IPOs

.It is actually an extraordinarily occupied Friday for biotech IPOs, with Zenas BioPharma, MBX and B...